Investor FAQs | Emergent BioSolutions Inc.

Show all

Where is Emergent BioSolutions’ corporate headquarters?: The Company is headquartered in Gaithersburg, Maryland. Click here for Company contact information.
Where is Emergent BioSolutions incorporated?: The Company is incorporated in the state of Delaware.
When did Emergent BioSolutions go public? What was the price?: The Company’s initial public offering occurred on November 15, 2006, at a price of $12.50 per share.
Where is Emergent BioSolutions’ stock traded?: The Company’s common stock is traded on the New York Stock Exchange under the ticker symbol “EBS”. Click here to view a stock quote.
What is the CUSIP number of Emergent BioSolutions’ common stock?: The CUSIP number for the Company’s common stock is 29089Q 10 5.
What is Emergent BioSolutions’ fiscal year?: The Company operates on a calendar quarterly basis, with its year ended December 31.
Who is Emergent BioSolutions’ transfer agent?: The Company’s transfer agent and registrar is American Stock Transfer and Trust. They can be contacted at the following:

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
(toll free) 1-877-830-4936
(international) 720-378-5591
(website) www.shareholder.broadridge.com
Whom do I contact with questions about my stock?: Contact the Company’s transfer agent and registrar as follows:

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
(toll free) 1-877-830-4936
(international) 720-378-5591
(website) www.shareholder.broadridge.com
How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?: Contact the Company’s transfer agent and registrar as follows:

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
(toll free) 1-877-830-4936
(international) 720-378-5591
(website) www.shareholder.broadridge.com
Does Emergent BioSolutions have a direct stock purchase plan?: No, the Company’s stock can only be purchased through any registered stock broker.
Who is Emergent BioSolutions’ auditor?: The Company is audited by Ernst & Young, LLP.
Does Emergent BioSolutions pay dividends?: The Company currently intends to retain all of its future earnings to finance the growth and development of its business. The Company does not intend to pay cash dividends to its stockholders in the foreseeable future.
Where can I get the latest corporate news releases and financial reports?: The Company’s news releases can be viewed under Press Releases.
How can I view documents Emergent BioSolutions has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?: The Company’s filings with the Securities and Exchange Commission can be viewed under SEC Filings.
Who makes up the Emergent BioSolutions Executive Management team and Board of Directors?: Click here for the Company’s Management Team or Board of Directors.
How can I obtain further information or materials on Emergent BioSolutions?: For copies of the Company’s Investor information, please click here. For an online version of the Company’s Investor kit, please click here.
Whom should I contact regarding investor inquiries?: All investor inquiries are to be directed to the following:

Rich Lindahl
Executive Vice President, Chief Financial Officer
E-mail: lindahlr@ebsi.com.